Nancy Devlin | Lightnews

Prof Nancy Devlin

@prof-nancy-devlin.bsky.social

1K followers 610 following 110 posts

Editor in Chief at Value in Health, Board chair at EuroQol Research Foundation, Rotterdam & Professor of Health Economics at University of Melbourne. Proud mum of three wonderful adults and grandma to two very energetic tiny humans. .. more

Videos

Economics 69%

Public Health 15%

Posts Replies Media Videos

Reposted by Nancy Devlin

EuroQol Research Foundation @euroqol.bsky.social · Aug 19

EQ-TIPS was developed to meet growing interest in evaluating the effectiveness & cost-effectiveness of treatments in very young children 👶

In this paper, @prof-nancy-devlin.bsky.social et al. examine issues in valuing the EQ-TIPS and possible adaptations to valuation methods 👉 bit.ly/4oxl4gF

Text: ‘Publication, Paper Tuesday - Valuing health states for infants and toddlers: challenges and methodological considerations in EQ-TIPS preferences elicitation. by Devlin, N. et al. (2025).' The background is a gradient blue with overlaid images of books and the world map.

Prof Nancy Devlin @prof-nancy-devlin.bsky.social · Jul 28

in a good way, though, I hope! :-)

Prof Nancy Devlin @prof-nancy-devlin.bsky.social · Jul 27

New paper: "Measuring & Valuing Health Using EuroQol Instruments: New Developments 2025 and Beyond"

▶️open access: tinyurl.com/EuroQol2025u...

@fengtastic.bsky.social @beaunebeaune.bsky.social @ellystolk.bsky.social

#HealthEconomics #PROMS #HRQOL #EQ-5D #EQ-5D-Y #EQ-HWB-9 #EQ-TIPS #Bolt-ons

Highlight points from a new paper summarising established and new tools for measuring and valuing health related quality of life, developed by a not for profit organisation called the EuroQol Research Foundation.

Reposted by Nancy Devlin

Rachel Sachs @rachelsachs.bsky.social · Jan 17

Now up at Health Affairs, my 2024 year in review in pharma policy (IRA implementation, PBM scrutiny, the election, and more), and a look ahead to 2025 (in addition to the above, a focus on 340B and important cases involving Judges O'Connor and Kacsmaryk). www.healthaffairs.org/content/fore...

Prescription Drug Policy, 2024 And 2025: The Year In Review And The Year Ahead | Health Affairs Forefront

In this article, I review five key developments from the past year and offer five items to watch for in 2025.

www.healthaffairs.org

Reposted by Nancy Devlin

Tempus Fugit @teacherclerio.bsky.social · Mar 1

www.nytimes.com/2025/02/28/u...

Trump to Sign Order Designating English as Official Language of the U.S. (Gift Article)

The order is expected to be largely symbolic but would be a victory for America’s English-only movement, which has long had ties to efforts to reduce immigration and restrict bilingual education.

www.nytimes.com

Reposted by Nancy Devlin, Kathryn A. Phillips

Institute for Clinical and Economic Review (ICER) @icer-review.bsky.social · Mar 18

Health Economics Methods Advisory Group Selects First Area for Study: Assessing Treatment Benefits Appropriate to Consider in HTA Decision-Making icer.org/news-insight...

#heor #hta

Health Economics Methods Advisory Group Selects First Area for Study: Assessing Treatment Benefits Appropriate to Consider in HTA Decision-Making - ICER

The Health Economics Methods Advisory group will conduct an assessment of the benefits of treatment that are appropriate to consider in health technology assessment.

icer.org

Reposted by Nancy Devlin, Jason R. Guertin, Ankur Pandya

A/Professor Bonny Parkinson @bonnyeconomist.bsky.social · Mar 26

Thank you ChatGPT. I shouldn’t give up my day job yet. #healtheconomics #HTA

Reposted by Nancy Devlin

NIHR Applied Research Collaboration (ARC) West @arc-west.bsky.social · Apr 3

🪇We're excited to announce ImplementEcon, a new network to unite implementation scientists and health economists to connect, collaborate and develop better methods

Led by @csrejon.bsky.social, Lane Carrandi and Robert Heggie

#ImplementationScience #HealthEconomics
bit.ly/3XHTykW

New network aims to unite implementation scientists and health economists - ARC West

A new network will bring together implementation scientists, health economists and beyond to collaborate and develop better methods. Led by researchers from Birmingham, Bristol, Glasgow and Melbourne,...

bit.ly

Reposted by Edward C. Norton, Nancy Devlin

ASHEcon @ashecon.bsky.social · Apr 16

Congratulations to Martin Gaynor, this year's winner of the Victor R. Fuchs Award for Lifetime Contributions to the Field of Health Economics. @martingaynor.bsky.social

Learn more about the ASHEcon Awards here 👉 www.ashecon.org/2025-ashecon...

Reposted by Nancy Devlin

David Bradford @bradfowd1.bsky.social · Apr 18

Oh man, if I get one of those for Health Economics, not only am I going to post it everywhere, I’m going to print it out on high quality cotton bond, frame it, and hang that bastard on my office wall so I can laugh at it every day.

Right after I write back that they can go fuck themselves.

Eric Reinhart @eric-reinhart.com · Apr 17

The Trump regime is now using US Attorneys to intimidate academic journals by sending them letters demanding they explain how they ensure ‘viewpoint diversity.’ Journal editors should be public about this and coordinate to refuse to comply with these fascist tactics.

Reposted by Nancy Devlin

Paul Kind @paul-kind.bsky.social · Jan 20

It seems appropriate to use today as the turning-away point when departure from Twitter (X) becomes inevitable. Trump (with/out Musk) represents such a bleak future for us all, a confirmation of the absurdity of the US electoral system and its governance. So, farewell to X and removal to Bluesky.

Reposted by Nancy Devlin

EuroQol Research Foundation @euroqol.bsky.social · May 14

Brand new selection of scientific papers on EuroQol instruments listed below - check them all out! 📚

1/

Reposted by Nancy Devlin

Prof Nancy Devlin @prof-nancy-devlin.bsky.social · Apr 25

How are X and @bsky.app performing as platforms for disseminating research? Fascinating @altmetric.com analysis here:
www.altmetric.com/blog/bluesky...
#AcademicSky #EconSky

Bluesky’s ahead, but is X a dead parrot?

Altmetric has been capturing and integrating Bluesky posts since October 2024. What does the data look like now?

www.altmetric.com

Prof Nancy Devlin @prof-nancy-devlin.bsky.social · Jul 23

Thanks @frasermorton.bsky.social for adding the Australian value set for the EQ-5D-Y-3L to your #rstats #EQ5D package! That was quick work!

@euroqol.bsky.social @rich-norman.bsky.social
Our paper is available here, open access:
➡️https://tinyurl.com/AussieY-3Lvalueset

Prof Nancy Devlin @prof-nancy-devlin.bsky.social · Jul 12

I'm looking forward to the 2025 #iHEA Congress, & the pre-congress @euroqol.bsky.social session.

Authors: If you're presenting a paper at iHEA & thinking of submitting it to #ValueinHealth - drop me a message! I'll do my best to come to your session. Or just come up & say hi!

#healtheconomics #VIH

Reposted by Lotte Steuten, Paula Lorgelly

Prof Nancy Devlin @prof-nancy-devlin.bsky.social · Jul 11

Will Trump's plan to use 'Reference Pricing' cut US drug prices? This #ValueinHealth paper by Grueger, Martin & Sullivan argues reference pricing is ill-advised & will lead to unintended consequences.

open access 👉 tinyurl.com/reference-pr...

#Trump #HealthEconomics

Image is copyright to Jane Doe/ Shutterstock. Shows a cartoon image of Donald Trump with a signed Executive Order

Prof Nancy Devlin @prof-nancy-devlin.bsky.social · Jun 22

News from the English NHS: www.bbc.com/news/article...

#genomics #precisionmedicine
@eigen-uom.bsky.social

NHS plans to DNA test all babies in England to assess disease risk

Scheme is part of the government's 10-year plan for the NHS in England aimed at easing pressure on services.

www.bbc.com

Prof Nancy Devlin @prof-nancy-devlin.bsky.social · Jun 22

New impact factor for Value in Health. We're chuffed!
#healtheconomics

Prof Nancy Devlin @prof-nancy-devlin.bsky.social · Jun 22

This letter, in the June issue of Value in Health, makes for pretty interesting reading:
www.valueinhealthjournal.com/article/S109...

#healtheconomics #equity #HTA

Why Is Distributional Cost-Effectiveness Analysis Not Ready for Prime Time in Health Technology Assessment?

The systematic review by Merga et al1 examining economic evaluations that address inequalities in cancer care had a striking result in that only 13% of studies identified used distributional cost-effe...

www.valueinhealthjournal.com

Prof Nancy Devlin @prof-nancy-devlin.bsky.social · Jun 22

New Value in Health paper, "Drop the M", of interest to anyone struggling with how to interpret data from patient reported outcome measures, and what a Minimally Important Difference means. Authors: Vickers, Nolla & Cella.
👉 pubmed.ncbi.nlm.nih.gov/40216310/

#HealthEconomics

Drop the "M": Minimally Important Difference and Change Are Not Independent Properties of an Instrument and Cannot Be Determined as a Single Value Using Statistical Methods - PubMed

MID must be estimated within a specific study context. It is best to think of PRO measures in terms of "ID" and leave the "M" to case-by-case, context-based interpretation.

pubmed.ncbi.nlm.nih.gov

Prof Nancy Devlin @prof-nancy-devlin.bsky.social · Jun 18

Thank you!! 👍

Prof Nancy Devlin @prof-nancy-devlin.bsky.social · Jun 15

Hey @altmetric.com, I was wondering if you've got any updates on this you could share? #AcadmicSky #EconSky

Prof Nancy Devlin @prof-nancy-devlin.bsky.social · Apr 25

How are X and @bsky.app performing as platforms for disseminating research? Fascinating @altmetric.com analysis here:
www.altmetric.com/blog/bluesky...
#AcademicSky #EconSky

Bluesky’s ahead, but is X a dead parrot?

Altmetric has been capturing and integrating Bluesky posts since October 2024. What does the data look like now?

www.altmetric.com

Reposted by Joanne Spetz

Prof Nancy Devlin @prof-nancy-devlin.bsky.social · May 17

Nice work @lauratrigg.bsky.social! 🙌 We need to see much more of this kind of evidence on the cost effectiveness of existing healthcare interventions. b.t.w,@jappleby123.bsky.social @koonalshah.bsky.social looked at hip surgery in 2013, using NHS PROMS data: pubmed.ncbi.nlm.nih.gov/23759892/

Using patient-reported outcome measures to estimate cost-effectiveness of hip replacements in English hospitals - PubMed

Using the new patient-assessed health-related quality of life data combined with routine hospital-level cost data it is possible to estimate a procedure-based measure of efficiency for hospitals. The ...

pubmed.ncbi.nlm.nih.gov

Prof Nancy Devlin @prof-nancy-devlin.bsky.social · May 16

Tomorrow at #ISPOR2025: in this 75-min 'spotlight' session we will give in-depth consideration of whether Cost Benefit Analysis could play a bigger role in HTA. If you are here in Montreal, I hope to see you there!
#HealthEconomics

A powerpoint slide from Prof. Devlin linking the case for CBA to the need for cross-sectoral economic evaluation

Prof Nancy Devlin @prof-nancy-devlin.bsky.social · May 16

An update on NICE methods regarding health inequalities in health technology evaluations is out now:

tinyurl.com/NICEmethodsh...

#HealthEconomics

Health inequalities - an update to NICE’s methods for health technology evaluation

www.nice.org.uk

Prof Nancy Devlin @prof-nancy-devlin.bsky.social · May 14

@euroqol.bsky.social puts out these useful posts regularly, where they do a quick ‘round-up ’ of new papers published about EQ-5D and related instruments. I find therir posts very helpful. If you’re interested in HRQoL, utilities etc, it’s worth following them!
#HealthEconomics #PROMs

EuroQol Research Foundation @euroqol.bsky.social · May 14

Brand new selection of scientific papers on EuroQol instruments listed below - check them all out! 📚

1/

Prof Nancy Devlin @prof-nancy-devlin.bsky.social · May 14

#ISPORAnnual Virginia Acha notes that tough pricing regulation in the US will reduce incentives for investment in innovation - and this is a double whammy if coupled with reduced US funding of basic science.
#referencepricing #HealthEconomics

Prof Nancy Devlin @prof-nancy-devlin.bsky.social · May 14

At ISPOR 2025 Darius Lakdawalla: some form of price intervention is now inevitable in the US, hopefully based on value, and done in a ‘US specific way’. Time for the US to adopt its own HTA.

Prof Nancy Devlin @prof-nancy-devlin.bsky.social · May 14

At today’s ISPOR conference: Sean Sullivan arguing US reference pricing is ‘lazy and misguided’ - but has bipartisan support.

Prof Nancy Devlin @prof-nancy-devlin.bsky.social · May 13

I'm guessing this is going to be a hot topic of conversation here at ISPOR Montreal over the coming days!
www.theguardian.com/business/202...
#HealthEconomics

Drug price cuts: what is Trump planning and what will it mean for big pharma?

President has directed Robert Kennedy to send price targets to industry, with slimming drugs thought to be included

Light upyour news

Sign in to Lightnews

Sign up to start reading

Connect Bluesky

Connect with Bluesky

Light up
your news